Tag: Switzerland

Our response to #COVID-19 starts with the health and safety of our employees, donors and patients. Learn more about what we’re doing in this rapidly evolving situation. https://t.co/KhYeJQ877t pic.twitter.com/l9q1bhdyOw

— CSL Behring (@CSLBehring) March 23, 2020

Watch: virtual #golf lessons from pro Perry Parker stepped up w/video lessons after the pandemic postponed #CSLBehringJNC sports competition for the #bleedingdisorders community. He shares his tips for a great golf game & living with #hemophilia https://t.co/9vl7GDE3zV

— CSL Behring (@CSLBehring) September 25, 2020

https://twitter.com/CSLBehring/status/1308772688744402945

THANK YOU to all the recovered #COVID-19 patients donating their plasma to help us make a potential treatment! Visit https://t.co/gmG1K6qd9X to join them! #donateplasma pic.twitter.com/VUoQTjyOgu

— CSL Behring (@CSLBehring) September 19, 2020

Our with @TheEIU ‘Suffering in Silence: Assessing Rare Disease Awareness and Management in Asia-Pacific’ finds delays in diagnosis, inadequate access to best evidence-based care and more issues to tackle for #raredisease patients. Details: https://t.co/GWdRntzEXQ pic.twitter.com/25TogvMHT5

— CSL Behring (@CSLBehring) September 19, 2020

Ventilation is now seen as a key strategy to prevent the spread of #COVID19. https://t.co/TBPO5NRjIR

— CSL Behring (@CSLBehring) September 17, 2020

Newborn screening is a lifeline for the tiniest #raredisease patients. Find out how it can catch rare diseases before babies leave the hospital. https://t.co/cRGUSdOTAX @RareDiseases

— CSL Behring (@CSLBehring) September 16, 2020

Will it be safe for someone with a primary immunodeficiency to get the #COVID19 vaccine? https://t.co/L0a5k94Y3q #PI @IDFCommunity

— CSL Behring (@CSLBehring) September 15, 2020

As many parents and children living with a #raredisease begin another week of working or learning from home, here is some expert advice on how to make it all work: https://t.co/3m7GpOj977 #MotivationMonday

— CSL Behring (@CSLBehring) September 14, 2020

https://twitter.com/CSLBehring/status/1304796954166210561

Looking for a new job? Our Chief Medical Officer and Head of R&D Bill Mezzanotte recently offered some lessons he's learned in his biotech journey in @Biopharma_asia. https://t.co/Zhy3bT31jA #careeradvice

— CSL Behring (@CSLBehring) September 10, 2020

Our partnership with @BaseLaunch gives us an inside look at cutting edge treatments and therapies under development, primarily in Europe. Learn more about it here: https://t.co/egSsuErou0

— CSL Behring (@CSLBehring) September 9, 2020

Our #Respiratory team is attending #ERSCongress this week sharing some of the great work we support, like this innovative research from @OSIC. Read more about their @Kaggle artificial intelligence approach in the fight against interstitial lung disease. https://t.co/D1jEmgAbp5

— CSL Behring (@CSLBehring) September 8, 2020

About a third of rare disease patients have experienced cancelled medical appointments due to #COVID19. Learn more about a survey conducted by @RareDiseases. https://t.co/m96j1henX4

— CSL Behring (@CSLBehring) September 4, 2020

#COVID19 isn't the only campus health concern. Get tips for how to manage a rare disease while at college. https://t.co/mBTFedWpKg #backtoschool

— CSL Behring (@CSLBehring) September 3, 2020

How well do you Zoom? At our patient summit, patient advocates received some expert advice on how to give an effective virtual presentation. https://t.co/BzI4GDn1C5

— CSL Behring (@CSLBehring) September 2, 2020

Our @CSL Chief Scientific Officer, Andrew Nash, got his start at @unimelb. Hear his advice for young #scientists who are just beginning their careers. https://t.co/JqIZxaksn7

— CSL Behring (@CSLBehring) August 30, 2020

https://twitter.com/CSLBehring/status/1298024868483563520

As we head into fall and winter, public health officials are urging vaccinations against the flu while #COVID19 continues to circulate, according to @nytimes. https://t.co/24EKWAHoKA

— CSL Behring (@CSLBehring) August 20, 2020

We're back to sponsor the @UCScienceCenter Nucleus Awards, which celebrate leaders and groundbreakers in innovation! Congrats to #Nucleus2020 Honorees Benjamin Doranz, @auroraarcher and @sylvestermobley. More here: https://t.co/ijOnWyNrGu pic.twitter.com/TTgxWltrU9

— CSL Behring (@CSLBehring) August 20, 2020

THANK YOU to all plasma donors donating during the #COVID19 pandemic. https://t.co/8AIgQn7TAL

— CSL Behring (@CSLBehring) August 15, 2020

This year, learning went online for everyone, including doctors. Learn about a series of webinars about immunoglobulin offered by CSL Behring in Taiwan. https://t.co/ZOHnKHFvSK #COVID19

— CSL Behring (@CSLBehring) August 13, 2020

It's #backtoschool time during a global pandemic. Get expert advice on how to adapt to uncertainty and changing conditions. https://t.co/7vikWwnKqP #COVID19

— CSL Behring (@CSLBehring) August 12, 2020

Our work on developing potential therapeutics to address #COVID19 is progressing around the world. https://t.co/VAbz3XlLdC

— CSL Behring (@CSLBehring) August 11, 2020

https://twitter.com/CSLBehring/status/1291147027003445250
https://twitter.com/CSLBehring/status/1288602726654455808
https://twitter.com/CSLBehring/status/1286722903405408256

We are one step closer to the development of a potential therapy with the CoVIg-19 Plasma Alliance. Our Bern facility successfully manufactured the clinical trial materials and now they are being sent to our Marburg location for packaging. #COVID19 https://t.co/wPrCYQwoLM pic.twitter.com/VBjX8Zq8on

— CSL Behring (@CSLBehring) July 22, 2020

This accomplished hiker @AlphaFriend just started a 3,100-mile journey to raise awareness about #Alpha1. https://t.co/EqrAWRLIg3 #Hikingforacure

— CSL Behring (@CSLBehring) July 20, 2020

With #COVID19 precautions in place, scientists have returned to the lab at sitem-insel in Bern, Switzerland. Get a peek behind the scenes with this photo gallery. https://t.co/lNfpUTnPJ5

— CSL Behring (@CSLBehring) July 17, 2020

https://twitter.com/CSLBehring/status/1284088067146620928

How can people living with a #raredisease or chronic illness cope with the long haul of the #COVID19 pandemic? This expert advice can help. https://t.co/N0ApKvIwSt

— CSL Behring (@CSLBehring) July 16, 2020

#ClinicalTrials can be an important potential resource for those living with a #raredisease. We're supporting @ACRPDC and @GGIgreatergift in the VOICE Campaign to raise awareness of clinical trials as a treatment option. More here: https://t.co/rPrc5ekOLS

— CSL Behring (@CSLBehring) July 15, 2020

We shouldn't underestimate the complexity of developing vaccines for #COVID19, which must be rigorously tested to prove they are safe and effective, says our @CSL CEO and Managing Director, Paul Perreault. https://t.co/wYUz9P6sAm

— CSL Behring (@CSLBehring) July 14, 2020

First-time donor? Find out 3 things to know about donating plasma. #donateplasma https://t.co/lPfSM7byLQ

— CSL Behring (@CSLBehring) July 12, 2020

Little is known about #COVID19 and #rarediseases. A patient with #HAE recently shared experience with @US_HAEA. https://t.co/nOoj8jY43E

— CSL Behring (@CSLBehring) July 10, 2020

After recovering from #COVID19, @SenBobCasey from Pennsylvania donated plasma recently at @CSLPlasma's Taylor, Pennsylvania, collection center. Learn more and find out how you can #donateplasma today- https://t.co/xGcwPcr0nz

— CSL Behring (@CSLBehring) July 9, 2020

As we gear up for #ISTH2020 we are proud to announce the 2020 recipients of our Prof. Heimburger Awards for #bleedingdisorders #research Learn more: https://t.co/PlUYSlDIyM pic.twitter.com/XN2wiYjoAm

— CSL Behring (@CSLBehring) July 9, 2020

#CSLBehring made three recent announcements about monoclonal antibodies. What are they? Here are 10 facts about "mAbs." https://t.co/xqX8gvW3Dn

— CSL Behring (@CSLBehring) July 7, 2020

Sharing medical data is a balancing act, according to an @eurordis survey of 2,000 #raredisease patients. https://t.co/JmFsOLybyU

— CSL Behring (@CSLBehring) July 6, 2020

“Everybody wants to get everybody to speed up and try to get rid of red tape. A reason that some of that tape is there is for safety purposes, when you know you're going to have to be giving billions of doses of this vaccine, you want to make sure you're doing the right thing.” https://t.co/ty12i1jMSL

— CSL Behring (@CSLBehring) July 6, 2020

Today we announce another important step in the fight against #COVID-19. The 1st patient is enrolled in study to assess our monoclonal antibody to treat patients suffering from severe respiratory distress. Learn more here: https://t.co/3MQXCABaXH pic.twitter.com/FCVTwBokpL

— CSL Behring (@CSLBehring) July 6, 2020

❓❓❓ Can you pass this quiz from from @UNICEF about #COVID19? https://t.co/0XH2qsW9Wv

— CSL Behring (@CSLBehring) July 5, 2020

When the weather heats up, how can you keep your meds cool? We offer 3 tips: https://t.co/JOrDMCAVcb

— CSL Behring (@CSLBehring) July 3, 2020

⭐⭐⭐Star power: "You've got a lot of fight in you" if you survived COVID-19, says Dame Helen Mirren. If you’ve recovered from #COVID19, find out how you can #donateplasma. https://t.co/CZ1fJCKmTh

— CSL Behring (@CSLBehring) July 1, 2020

Did you know there is more than one type of hemophilia? Learn about #HemophiliaB: https://t.co/VJp4YeJ7iU

— CSL Behring (@CSLBehring) June 29, 2020

Despite the #COVID19 pandemic, #CSLBehring remains on track with an expansion project in Bern, Switzerland, that will serve an additional 90,000 patients. https://t.co/34KbOFyohp

— CSL Behring (@CSLBehring) June 25, 2020

Today we are announcing an agreement to acquire @uniQure_NV’s phase 3 gene therapy product, currently being studied to treat hemophilia B. Learn more here: https://t.co/HSPge0kg4R pic.twitter.com/wlIt4XqYFt

— CSL Behring (@CSLBehring) June 24, 2020

How do you decide if it's safe to do this or that amid the evolving #COVID19 pandemic? Dr. Kate Sullivan of @ChildrensPhila offers guidance for people who have #primaryimmunodeficiencies. https://t.co/pHAt1JZXrD @IDFCommunity

— CSL Behring (@CSLBehring) June 22, 2020

Today is #WorldSickleCellDay Patients have been waiting a long time for a breakthrough. Read our expert's thoughts on what’s next for those who face the prospect of pain, organ damage and shortened life spans. https://t.co/SVNbU269Up #CSLBehring pic.twitter.com/2jrrYhRRJj

— CSL Behring (@CSLBehring) June 19, 2020

Educate. Empower. Inform. 3 important pieces to being a caregiver for a loved one with #SickleCellDisease. Friday is #WorldSickleCellDay Learn more here: https://t.co/BIafJp6wKc pic.twitter.com/Y5pMw4Es0G

— CSL Behring (@CSLBehring) June 18, 2020

The CoVIg-19 Plasma Alliance is now part of a nationwide coalition in an effort to further encourage recovered #COVID19 patients to #donateplasma. Learn more about the initiative: https://t.co/3jsboOi91V #TheFightIsInUs https://t.co/yAzjfYmXYl

— CSL Behring (@CSLBehring) June 17, 2020

From crucial catches in the @NFL to crucial support for sickle cell families. Listen to former @SuperBowl MVP Santonio Holmes’ story here https://t.co/O4GMwVgLvu @IIIandLong #GreaterThanSickleCell #WorldSickleCellDay

— CSL Behring (@CSLBehring) June 16, 2020

Surfer Arran Strong rides waves and spreads a message of hope to people who have respiratory diseases like #Alpha1. https://t.co/WWpbtvnpHJ

— CSL Behring (@CSLBehring) June 15, 2020

What do spoons have to do with chronic illness? Find out how it became a symbol for those who must manage their health and their daily energy. https://t.co/COakx1eAKl

— CSL Behring (@CSLBehring) June 14, 2020

“Our commitment to delivering innovative treatments for people with #bleedingdisorders is stronger than ever,” says Antti Kourula, VP, Hematology ahead of #WFHVirtualSummit. Read the full release: https://t.co/nhLJ9t1Urp @wfhemophilia pic.twitter.com/YhgTERQYI3

— CSL Behring (@CSLBehring) June 12, 2020

Together with @seattlechildren, #CSLBehring plans to develop treatment options for two, rare, life-threatening #primaryimmunodeficiency diseases. https://t.co/hp3p5RXys7 #PI @IDFCommunity

— CSL Behring (@CSLBehring) June 11, 2020

Our latest #podcast dives into how clinical trials play an important role in developing therapies for patients, and why as the #COVID-19 pandemic continues to impact people around the world, clinical trials are more important than ever. https://t.co/hN647CrmAL pic.twitter.com/D88tTw4nUx

— CSL Behring (@CSLBehring) June 10, 2020

Employees are exemplifying #PatientFocus by donating plasma for our necessary therapies. https://t.co/EeUvIP9ECd

— CSL Behring (@CSLBehring) June 10, 2020

If you're new to wearing a face mask, here are 5 tips for making it work. https://t.co/fIn67zQYk3 #COVID19

— CSL Behring (@CSLBehring) June 8, 2020

Today, we take an important next step in growing our portfolio of promising products in late-stage development to address the significant unmet needs of #transplant recipients. @vitaerisbio is now part of #CSLBehring https://t.co/lSDciA8qfA pic.twitter.com/E46SQPk5a5

— CSL Behring (@CSLBehring) June 8, 2020

Organ #transplants continue despite #COVID19. This week, CSL Behring awarded two grants in transplant medicine during #ATC2020 to @Paulo_MartinsMD of @UMassMedical and @umassmemorial and Dr. Yang Yang of @UTHealth. https://t.co/NRJgLDB1q5 @ATCMeeting @ASTSChimera @AST_info

— CSL Behring (@CSLBehring) June 3, 2020

"The plasma they have is rich in these antibodies and can save the lives of other individuals down the road. So it is a chance to pay it forward," Bill Mezzanotte, Executive Vice President, Head Research & Development told @AliciaNews8 @CBS8 #COVID19 https://t.co/uFo4LDQhRV

— CSL Behring (@CSLBehring) May 29, 2020

@CSLBehring, medical researchers & other groups making up a nationwide coalition in the fight against coronavirus have joined forces. If you’ve recovered from #COVID19, find out how you can #donateplasma. https://t.co/WhvJcBqW8g https://t.co/R4WcYpP1jB

— HemophiliaFederation (@hemophiliafed) June 18, 2020

We're delighted to strengthen our partnership with @DrexelCCI and @CSLBehring with Yi Deng and Bill Mezzanotte joining our Board. https://t.co/lPuXAyl1Or pic.twitter.com/giGRxCQ5KP

— Science Center (@UCScienceCenter) June 19, 2020

#PennStateBiotechDay @InventPennState @CSLBehring CSL Behring Fermentation Facility @PennState highlighted as a critical resource for Penn State's innovative research @PSUresearch pic.twitter.com/fM7DxhucoE

— Center of Excellence in Industrial Biotechnology (@huckcenters) June 12, 2020

In response to the global emergency precipitated by COVID-19, CSL has announced three agreements to secure supply of two COVID-19 vaccines for Australia, should the vaccines prove successful in clinical trials. Read more here https://t.co/6C5GGL6BUQ #COVID19 pic.twitter.com/QCu0xdMm6o

— CSL (@CSL) September 7, 2020

Sir Frank was one of the most distinguished figures in biological sciences in Australia. His pioneering research & discoveries left a lasting legacy. Our library in Parkville is proudly named in honour of his significant contribution to CSL as a long-term friend & collaborator. https://t.co/oAQfW1E0VR

— CSL (@CSL) September 4, 2020

Announcing CSL’s FY results, Mr Paul Perreault, CEO & MD said, “Our result is a reflection of the focus we have to deliver our strategy and on our promise to provide innovative medicines for patients and public health around the world.” pic.twitter.com/uhRiW5OPJI

— CSL (@CSL) August 18, 2020

Work is now underway at the Broadmeadows facility to develop a hyperimmune globulin to assist in treating COVID-19. Read more about the treatment here https://t.co/3ECCKiapM4 #covid19

— CSL (@CSL) August 12, 2020

Commenting on a new collaboration with @UniQuestUQ, CSL’s Chief Scientific Officer, Dr Andrew Nash, said “This is another example of Australian research excellence, harnessing the strengths of both industry and academia to address an important area of unmet medical need.” https://t.co/80qsWHshOb

— CSL (@CSL) July 20, 2020

CSL’s Prof. Andrew Cuthbertson explains why it’s important to test safety and efficacy in the development of a COVID-19 vaccine candidate. #covid19 https://t.co/MrpTSq5l85

— CSL (@CSL) July 20, 2020

Congratulations to the University of Queensland, who have today commenced the first human trials of their COVID-19 vaccine. This is an exciting milestone for #UQ and we look forward to continuing to work together on this important project. https://t.co/dkSBCpIuRs

— CSL (@CSL) July 13, 2020

Applications for the CSL Centenary Fellowship are now open. Here is Dr Daniel Pellicci, one of the 2019 fellowship recipients, talking about his research recruiting specialist white blood cells to help fight tuberculosis (TB) #CSLcentenaryfellowship https://t.co/fqafIhHrIg

— CSL (@CSL) July 7, 2020

Ever wondered what happens to a #COVID19 swab test? This video explains the journey of a swab test and highlights the important role of #science in addressing the current pandemic. https://t.co/T543DgVnRz

— CSL (@CSL) July 3, 2020

.@AAMRI_Aus share a video highlighting the efforts of Australian medical researchers throughout the #COVID19 pandemic. #medicalresearch https://t.co/MnPUAySj7z

— CSL (@CSL) June 30, 2020

CSL is excited to be part of @WEHI_research led Australian consortium focused on finding new anti-viral medicines to treat COVID-19. Thank you to @GregHuntMP, who earlier this month announced MRFF funding for the program. https://t.co/bwRw9V1q2C

— CSL (@CSL) June 18, 2020

Listen to a recent podcast with Deirdre BeVard, @CSLBehring ’s Senior Vice President of R&D Strategic Operations, who discusses the importance of #clinicaltrials and how they benefit patients. https://t.co/7SQS1OiDR5

— CSL (@CSL) June 10, 2020

CSL, @CEPIvaccines and #UQ today announced a partnering agreement to accelerate the development, manufacture and distribution of a #COVID19 vaccine candidate, utilising #UQ’s “molecular clamp” enabled vaccine. #UQ aim to commence phase 1 clinical trials in July. pic.twitter.com/OeVshf9wDO

— CSL (@CSL) June 5, 2020

A new rapid research brief on the evidence for how long the SARS-CoV-2 virus remains viable on different surfaces, particularly clothes, cardboard, plastic, stainless steel, and copper. https://t.co/vSPbcwJApI

— CSL (@CSL) May 29, 2020

Damian got coronavirus. Now he's part of the quest to outwit it https://t.co/2kwvGHatbB via @ABCNews @davidantibiotic @syctong @TheDohertyInst @lifebloodau @CSL @WEHI_research

— Dr Catherine Hanrahan (@CathHanrahan1) August 5, 2020

#Didyouknow Nobel Laureate Karl Landsteiner, who discovered and classified ABO human blood groups, also discovered the virus that causes polio?

Today thanks to a worldwide effort, two out of the three wild poliovirus strains have been completely eradicated.

Image: Polio vaccine pic.twitter.com/966hzuV7dU

— The Nobel Prize (@NobelPrize) June 14, 2020

CSL Plasma App Takes Donors on a Plasma Journey: App offers a personalized experience for plasma donors. https://t.co/y2FXRblkXr

— CSL Plasma (@CSLPlasma) September 2, 2020

We do have a few requirements for our donors, and it’s all to ensure we keep you safe to come back and continue giving more.
Learn more: https://t.co/GhXdnlxeWO pic.twitter.com/Zh450NMCdV

— CSL Plasma (@CSLPlasma) July 23, 2020

Donations are needed more than ever. Become a donor today!
Help people around the world while earning up to $400.
Learn more by going to: https://t.co/X3SvsTeEIx pic.twitter.com/IniTGEku2J

— CSL Plasma (@CSLPlasma) May 19, 2020